Clinical Trial Update: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH) [NA]

View source ↗

Summary

Completed first-in-human study update on the SurVeil Drug-Coated Balloon showing safety and efficacy signals for treating hemodialysis access failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodialysis Access Failure

Drugs mentioned

• SurVeil Drug-Coated Balloon (paclitaxel-coated balloon)

Snippet

Sponsor: SurModics, Inc. | Conditions: Hemodialysis Access Failure | NA | Status: COMPLETED | Results posted: 2022-09-29